paclitaxel has been researched along with Polycystic Kidney Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bawumia, S; Chiu, MG; Dahm-Vicker, EM; Guay-Woodford, L; Hillman, KA; Hughes, RC; Johnson, TM; Long, DA; Poirier, F; Venner, K; Winyard, PJ; Woolf, AS | 1 |
Woolf, AS | 1 |
Miao, SY; Pelayo, JC; Woo, DD; Woolf, AS | 1 |
Cowley, BD; Gattone, VH; Grantham, JJ; Kaneta, S; Martinez, JR; Nagao, S; Takahashi, H; Yamaguchi, T | 1 |
Tabancay, AP; Wang, CJ; Woo, DD | 1 |
Avner, ED; Sommardahl, CS; Sweeney, WE; Wilkinson, JE; Woychik, RP | 1 |
6 other study(ies) available for paclitaxel and Polycystic Kidney Diseases
Article | Year |
---|---|
Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease.
Topics: Animals; Animals, Genetically Modified; Cells, Cultured; Centrosome; Cilia; Cysts; Galectin 3; Kidney; Kidney Tubules, Collecting; Mice; Mice, Inbred C57BL; Paclitaxel; Polycystic Kidney Diseases | 2006 |
Cures for polycystic kidney diseases?
Topics: Animals; Disease Models, Animal; Humans; Paclitaxel; Polycystic Kidney Diseases | 1994 |
Taxol inhibits progression of congenital polycystic kidney disease.
Topics: Animals; Body Weight; Cells, Cultured; Disease Models, Animal; Humans; Kidney; Mice; Microtubules; Organ Size; Paclitaxel; Polycystic Kidney Diseases | 1994 |
The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Topics: Animals; Disease Progression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Heterozygote; Homozygote; Kidney; Male; Mice; Mice, Inbred C57BL; Paclitaxel; Polycystic Kidney Diseases; Random Allocation; Rats; Rats, Inbred Strains; Renal Agents | 1997 |
Microtubule active taxanes inhibit polycystic kidney disease progression in cpk mice.
Topics: Alkaloids; Animals; Kidney; Mice; Mice, Inbred C57BL; Microtubules; Paclitaxel; Polycystic Kidney Diseases; Structure-Activity Relationship; Taxoids | 1997 |
Efficacy of taxol in the orpk mouse model of polycystic kidney disease.
Topics: Aging; Alkaline Phosphatase; Animals; Antineoplastic Agents, Phytogenic; ErbB Receptors; Genes; Immunohistochemistry; Kidney; Liver; Mice; Mutation; Osmolar Concentration; Paclitaxel; Polycystic Kidney Diseases | 1997 |